PharVision Capital was founded in 2020 in Chicago, IL as a systematic long-short, market-neutral, factor-neutral investment fund, capturing opportunities in the US-listed equity markets. PharVision is looking to deliver superior uncorrelated returns to investors, i.e. pure alpha, through a machine-plus-man approach. The team is utilizing proprietary quality data sources, sound economic reasoning, machine learning signal generation, vast computational resources and airtight portfolio risk-management to drive performance. The culture is centered around meritocracy, collaboration, innovation, creativity, overcommunication, urgency and relentless ambition to grow our intellectual competitive advantage.
Company Details
- Employees
- 8
- Founded
- -
- Address
- 10055 Yamato Rd, 508,bulgaria
- Industry
- Financial Services
- NAICS
-
Finance and InsuranceMonetary Authorities-Central Bank
- Website
- http://www.pharvision.ai
- Keywords
- hedge fund, quantitative, systematic, machine learning, alternative data, artificial intelligence, market-neutral, factor-neutral, alpha, python.
- HQ
- Boca Raton, FL
Pharvision Capital Questions
Pharvision Capital's website is http://www.pharvision.ai
Pharvision Capital's LinkedIn profile is https://www.linkedin.com/company/pharvision
Pharvision Capital has
8 employees.
View email and phone details for 8
employees at Pharvision Capital.
Pharvision Capital's industry is
Financial Services
Pharvision Capital's top competitors are
Worldquant,
Bot Lab, Lp,
Bestex Research,
Kalpi Capital,
Asymptota,
Zeotap,
Peloton Equity,
Qube Research & Technologies,
Trexquant Investment Lp,
Citadel.
Pharvision Capital's categories are Financial Services
Pharvision Capital's founding year is 2020
